Guillain-Barré syndrome overview

Revision as of 19:16, 24 February 2012 by Priyamvada Singh (talk | contribs)
Jump to navigation Jump to search

Guillain-Barré syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Guillain-Barré syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural history, Complications, and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Guillain-Barré syndrome overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Guillain-Barré syndrome overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Guillain-Barré syndrome overview

CDC on Guillain-Barré syndrome overview

Guillain-Barré syndrome overview in the news

Blogs on Guillain-Barré syndrome overview

Directions to Hospitals Treating Guillain-Barré syndrome

Risk calculators and risk factors for Guillain-Barré syndrome overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editors-In-Chief: Priyamvada Singh, MBBS [2]

Overview

Guillain-Barré syndrome (GBS) is an acute, autoimmune, polyradiculoneuropathy affecting the peripheral nervous system, usually triggered by an acute infectious process. It is included in the wider group of peripheral neuropathies.

Historical perspective

It was first reported by Landry in 1859 as a case study of 10 patients with ascending paralysis. Later the characteristic features of the disease like flaccid paralysis, areflexia and CSF findings were reported by Guillain, Barré, and Strohl. The syndrome was later named Guillain-Barré syndrome after these physicians.

Pathophysiology

It involves an auto-immune mechanism in which the antibodies formed against the lipopolysaccharides of bacteria or certain vaccines cross reacts with the gangliosides present in myelin of peripheral nerves. As a result of which, myelin degeneration occurs leading to conduction defects that manifests as flaccid paralysis.

Epidemiology and demographics

The incidence is approximately 1.2 - 3 / 100,000 persons per year across the world. It is commoner in males compared to female and has two peaks (15-35 years and 50-75 years). Incidence is similar across different races.

Risk factors

Anyone can develop GBS; however, it is more common among older adults. The incidence of GBS increases with age, and people older than 50 years are at greatest risk for developing GBS. Since 1976, many studies have been done to see if other flu vaccines may cause GBS. In most studies no link was found between the flu vaccine and GBS. For the most part, the chance of getting very ill from flu is far higher than the chance of getting GBS after getting the flu vaccine.

Natural history, complications and prognosis

Approximately 80% of patients have a complete recovery within a few months to a year, although minor findings may persist. A patient's outcome is most likely to be very good when the symptoms go away within 3 weeks after they first started. Complications like paralysis, respiratory failure and hypotension can be seen in these patients.

Classification

There are several types of GBS, but unless otherwise stated, GBS refers to the most common form, acute inflammatory demyelinating polyneuropathy (AIDP). It is frequently severe and usually exhibits as an ascending paralysis noted by weakness in the legs that spreads to the upper limbs and the face along with complete loss of deep tendon reflexes. The other less common variants involve Miller Fisher syndrome, Acute motor axonal neuropathy (AMAN), Acute motor sensory axonal neuropathy(AMSAN), Acute panautonomic neuropathy, and Bickerstaff's brainstem encephalitis (BBE).

Causes

The exact cause of Guillain-Barre syndrome is unknown. However, it has been associated with an antecedence of minor infections (lung, sinus or diarrhea) with campylobacter jejuni. It has also been linked to flu vaccine but the incidence is rare.

Diagnosis

History and symptoms

Patient may present with an antecedence of mild infection of respiratory or gastrointestinal infections that may disappear before the onset of weakness. Many patients also give a history of pins and needles sensation before the onset of weakness of limbs. Symmetrical, bilateral, weakness of lower limbs followed by upper limb, trunk and cranial nerve may be seen. Sensory symptoms are usually mild and patients may complain of decreased or increased pain sensation, decreased touch and difficulty walking (loss of position sense) depending on stage and type of GBS. Autonomic involvement in form of urinary retention, constipation and awareness of own's heartbeat can be found. Cranial nerve involvement in form of blurred vision, facial drooping, difficulty in swallowing and speaking can be seen.

Physical examination

The physical examination findings usually indicates features due to autonomic dysfunction and demyelination of peripheral nerves. Fluctuation in vitals can be seen and may present as hyper or hypothermia, hypo or hypertension, brady or tachycardia. Progressive, symmetric, bilateral, flaccid, ascending paralysis progressing over weeks to days time is the common finding. Hypotonia, hyporeflexia, areflexia can be seen.Sensory system may be involved but generally it is mild. Ataxia and difficulty in walking may be seen despite great muscle strength due to involvement of proprioception and oculoparesis.

References

Template:WH Template:WS